Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) Enterprise Value (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Enterprise Value data on record, last reported at -$800.1 million in Q4 2025.

  • For Q4 2025, Enterprise Value fell 1095.35% year-over-year to -$800.1 million; the TTM value through Dec 2025 reached -$800.1 million, down 1095.35%, while the annual FY2025 figure was -$800.1 million, 1095.35% down from the prior year.
  • Enterprise Value reached -$800.1 million in Q4 2025 per CAI's latest filing, down from -$757.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$66.9 million in Q4 2024 and bottomed at -$800.1 million in Q4 2025.